A Plutocratic Proposal: an ethical way for rich patients to pay for a place on a clinical trial

Alexander Masters and Dominic Nutt
Journal of Medical Ethics 
Published Online First: 06 June 2017.

Abstract

Many potential therapeutic agents are discarded before they are tested in humans. These are not quack medications. They are drugs and other interventions that have been developed by responsible scientists in respectable companies or universities and are often backed up by publications in peer-reviewed journals. These possible treatments might ease suffering and prolong the lives of innumerable patients, yet they have been put aside. In this paper, we outline a novel mechanism—the Plutocratic Proposal—to revive such neglected research and fund early phase clinical trials. The central idea of the Proposal is that any patient who rescues a potential therapeutic agent from neglect by funding early phase clinical trials (either entirely or in large part) should be offered a place on the trial.

The article is here.

A new tactic to halt child abuse in Maryland

Focus now on helping low-risk families instead of punishing

By Yvonne Wenger
The Baltimore Sun
Originally posted July 5, 2014

Baltimore is changing the way it handles cases of alleged child abuse and neglect — part of a broad social-services strategy that has been touted by Maryland officials but abandoned in some other states.

The new approach, which is designed to lessen the adversarial relationship between families and caseworkers, puts cases on different tracks depending on whether they are deemed high or low risk. The tiered response, used in 23 states, is regarded as a best practice by many child advocates.

The entire story is here.